Role of GSK-3β in Regulation of Canonical Wnt/β-catenin Signaling and PI3-K/Akt Oncogenic Pathway in Colon Cancer

被引：54
|
作者：
Jain, Shelly [1 ]
Ghanghas, Preety [1 ]
Rana, Chandan [1 ]
Sanyal, S. N. [1 ]
机构：
[1] Panjab Univ, Dept Biophys, Chandigarh 160014, India
来源：
CANCER INVESTIGATION | 2017年 / 35卷 / 07期
关键词：
Akt; beta-catenin; colorectal cancer; DMH; GSK-3; beta; PI3-K; NITRIC-OXIDE SYNTHASE; ABERRANT CRYPT FOCI; BETA-CATENIN; PHOSPHATIDYLINOSITOL; 3-KINASE/AKT; CYCLOOXYGENASE-2; INHIBITOR; COLORECTAL-CANCER; DOWN-REGULATION; APOPTOSIS; CELECOXIB; DICLOFENAC;
D O I：
10.1080/07357907.2017.1337783
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Non-steroidal anti-inflammatory drugs (NSAIDs) are emerging as novel chemopreventive agents because of their ability in blocking cellular proliferation, and thereby tumor development, and also by promoting apoptosis. GSK-3 beta, a serine threonine kinase and a negative regulator of the oncogenic Wnt/beta-catenin signaling pathway, plays a critical role in the regulation of oncogenesis. Celecoxib and etoricoxib, the two cyclooxygenase-2 (COX-2) selective NSAIDs, and Diclofenac, a preferential COX-2 inhibitory NSAID, had shown uniformly the chemopreventive and anti-neoplastic effects in the early stage of colon cancer by promoting apoptosis as well as an over-expression of GSK-3 beta while down-regulating the PI3-K/Akt oncogenic pathway.
引用
收藏
页码：473 / 483
页数：11
相关论文
共 50 条
  • [1] Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: Exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/β-catenin signaling
    Vaish, Vivek
    Sanyal, Sankar Nath
    BIOMEDICINE & PHARMACOTHERAPY, 2012, 66 (05) : 354 - 367
  • [2] Oncogenic K-ras stimulates wnt signaling in colon cancer through inhibition of GSK-3β
    Li, JN
    Mizukami, Y
    Zhang, XB
    Jo, WS
    Chung, DC
    GASTROENTEROLOGY, 2005, 128 (07) : 1907 - 1918
  • [3] PI3-K and GSK-3: Akt-ing together with microtubules
    Buttrick, Graham J.
    Wakefield, James G.
    CELL CYCLE, 2008, 7 (17) : 2621 - 2625
  • [4] Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain
    Ozaita, Andres
    Puighermanal, Emma
    Maldonado, Rafael
    JOURNAL OF NEUROCHEMISTRY, 2007, 102 (04) : 1105 - 1114
  • [5] K-ras can inhibit GSK-3β and stimulate the Wnt signaling pathway in colon cancer
    Li, JN
    Mizukami, Y
    Zhang, XB
    Jo, WS
    Chung, DC
    GASTROENTEROLOGY, 2004, 126 (04) : A262 - A262
  • [6] Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer's disease
    Kitagishi, Yasuko
    Nakanishi, Atsuko
    Ogura, Yasunori
    Matsuda, Satoru
    ALZHEIMERS RESEARCH & THERAPY, 2014, 6 (03):
  • [7] Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer’s disease
    Yasuko Kitagishi
    Atsuko Nakanishi
    Yasunori Ogura
    Satoru Matsuda
    Alzheimer's Research & Therapy, 6
  • [8] Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin
    Ikeda, S
    Kishida, S
    Yamamoto, H
    Murai, H
    Koyama, S
    Kikuchi, A
    EMBO JOURNAL, 1998, 17 (05): : 1371 - 1384
  • [9] Evaluation of the effect of GSK-3β on liver cancer based on the PI3K/AKT pathway
    Guo, Jiageng
    Jiang, Xinya
    Lian, Jing
    Li, Huaying
    Zhang, Fan
    Xie, Jinling
    Deng, Jiagang
    Hou, Xiaotao
    Du, Zhengcai
    Hao, Erwei
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [10] DcR3 induces proliferation, migration, invasion, and EMT in gastric cancer cells via the PI3K/AKT/GSK-3β/β-catenin signaling pathway
    Ge, Hua
    Liang, Chaojie
    Li, Zhixia
    An, Dali
    Ren, Shulin
    Yue, Chaosen
    Wu, Jixiang
    ONCOTARGETS AND THERAPY, 2018, 11 : 4177 - 4187
12345